Wire
23:01ZEPOCHTIMESJudge rules U.S. Postal Service likely overstepped congressional authority with rule23:00ZWFWITNESSHouthi forces launched missiles and drones at Saudi cities, coalition says22:57ZFRANCE 24Zelensky says Ukraine ready to de-escalate if Russia halts strikes22:56ZTASNIMNEWSFive Yemeni civilians killed, wounded in Saudi airstrikes on Yemeni cities22:54ZBOWESCHAYLooks like a hell of a time22:50ZPRESSTVSupertanker hits sea mine in restricted waters south of Strait of Hormuz22:44ZFRANCE24ENMacklemore dropped from Ed Sheeran US tour after pro-Palestinian remarks22:42ZTHEJERUSALUS strikes two fishing vessels near Banda in Persian Gulf
  • S&P 500 ETF 0.05%
  • Nasdaq 0.56%
  • Nasdaq 100 0.82%
  • Dow ETF 0.07%
Terminal ↗
← The MonexusScience

A Cheap Antidepressant, a Long COVID Puzzle, and the Limits of a Single Trial

A 399-person randomized trial suggests fluvoxamine eases long COVID fatigue. The result is real, but the science behind it is messier than the headline.

A 399-person randomized trial suggests fluvoxamine eases long COVID fatigue.
A 399-person randomized trial suggests fluvoxamine eases long COVID fatigue. sciencedaily.com / Photography

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

  • https://t.me/themonexus/4df76be4a7
  • https://en.wikipedia.org/wiki/Fluvoxamine
  • https://en.wikipedia.org/wiki/Long_COVID
  • https://en.wikipedia.org/wiki/Selective_serotonin_reuptake_inhibitor
  • https://en.wikipedia.org/wiki/Randomized_controlled_trial
  • https://en.wikipedia.org/wiki/Placebo_effect
Intelligence ThreadFollow on terminal ↗
© 2026 Monexus Media · AI-native reporting from public-source material
The Monexus

Read with context.

Using this article and its related event records

Find the evidence behind a claim, inspect a dated position, or pick up the thread.

Source lookup is available to everyone. Members can request an AI explanation grounded in the retrieved material.

Browse event files →
A Cheap Antidepressant, a Long COVID Puzzle, and the Limits of a Single Trial - The Monexus